CTLA-4 promotes lymphoma progression through tumor stem cell enrichment and immunosuppression
The recurrence rate of lymphoma is very high, and tumor stem cells may be an important mechanism. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can inhibit antitumor immunity and promote cancer progression, but its role and mechanism in lymphoma are still unclear. Here we collected lymphoma t...
Guardado en:
Autores principales: | Chen Yan, Li Meng, Cao Jian, Cai Guohong, Li Xiantao, Liu Yuejiao, Chen Wen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86871cff5db446d0a4029a83abc1aef7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Primary central nervous system Hodgkin Lymphoma: A case discussion and a hypothesis on the etiology
por: Ahmad Alfaseh, et al.
Publicado: (2019) -
CTLA-4 blockade in the treatment of colorectal cancer with microsatellite instability
por: Diana Russo, et al.
Publicado: (2021) -
EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT
por: Jhanzeb Iftikhar, et al.
Publicado: (2021) -
Extranodal natural killer/T-cell lymphoma of the breast: a retrospective clinicopathological analysis of a consecutive 11-year case series
por: Wei Liu, et al.
Publicado: (2021) -
Polimorfismo +49 A/G del gen del antígeno 4 del linfocito T citotóxico (CTLA-4) en la diabetes tipo 1: Asociación con el perfil de anticuerpos y citoquinas
por: Pérez B,Francisco, et al.
Publicado: (2009)